AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 69 filers reported holding AADI BIOSCIENCE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,356,000 | – | 96,100 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $342,125 | 26.12% |
| Alerce Investment Management, L.P. | 1,630,830 | $20,923,549 | 24.07% |
| ACUTA CAPITAL PARTNERS, LLC | 1,849,402 | $19,622,228 | 12.08% |
| Ally Bridge Group (NY) LLC | 632,997 | $8,121,352 | 7.90% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $6,752,801 | 2.53% |
| Opaleye Management Inc. | 252,046 | $3,233,750 | 1.12% |
| Vivo Capital, LLC | 509,572 | $6,538 | 0.75% |
| Lynx1 Capital Management LP | 64,739 | $830,601 | 0.72% |
| Avoro Capital Advisors LLC | 2,849,402 | $36,557,828 | 0.55% |
| Ghost Tree Capital, LLC | 90,000 | $1,155,000 | 0.49% |